Skip to main content
. 2020 Nov 13;54:303–310. doi: 10.1016/j.breast.2020.11.008

Table 2.

Multivariate Cox regression analysis of prognostic factors for progression-free survival in endocrine therapy-naive and endocrine therapy-sensitive population.

Prognostic factors n HR (95CI) P value
ECOG status - no. (%) <0.001
0 119 1
1 63 1.4 (0.9–2.18)
2 15 3.96 (1.97–7.97)
Pretreated by endocrine therapy for advanced disease - no. (%) <0.001
No 169 1
Yes 49 2.38 (1.54–3.69)
Metastatic sites - no. (%) <0.001
1–2 151 1
3 and more 67 1.88 (1.26–2.82)